COVID-19 Disinfection & Outbreak Response

COVID-19 and respiratory-virus disinfection in 2026

CDC's current view is that SARS-CoV-2 spreads mainly through the air and that the risk from touching contaminated surfaces is generally low. For a healthcare facility that means surface disinfection still matters — mostly for the contact-spread organisms that share the same rooms — while ventilation and respiratory precautions do most of the work against the virus itself.

What we do during a case or outbreak

• Clean and disinfect the patient zone and high-touch surfaces with an EPA-registered product whose label includes SARS-CoV-2, used at its full contact time.
• Increase high-touch frequency in waiting rooms, check-in and shared restrooms for the period your infection preventionist sets.
• Terminal clean rooms used by symptomatic patients or residents after discharge or the end of isolation, following your facility policy.
• Keep HEPA-unit intakes, supply and return grilles clean so air-cleaning equipment keeps its airflow.

What we do not sell

Fogging or electrostatic spraying on its own is not a substitute for wiping surfaces, and "deep cleans" after every positive case in outpatient areas are not what current guidance supports. We will tell you when an extra service adds cost without adding protection.

For the full picture of which pandemic-era practices are worth keeping, read COVID-19 cleaning legacy: what to keep, and see our EPA-registered disinfectants guide.

Compliance, Certifications & Documentation

Massachusetts healthcare facilities are subject to multiple layers of regulatory oversight. Our cleaning protocols are designed to support your compliance program across:

• Massachusetts Department of Public Health (DPH): 105 CMR 130 hospital licensure, 105 CMR 140 clinic regulations, 105 CMR 150 long-term care facilities, and the local board of health's inspection authority.
• CDC Environmental Infection Control Guidelines: Cleaning sequences, contact times, and hand hygiene protocols aligned with CDC HICPAC recommendations.
• EPA-Registered Hospital-Grade Disinfectants: List N (SARS-CoV-2), List P (Candida auris), List H (MRSA and VRE) and List K (C. difficile) products applied with documented contact times.
• HIPAA Privacy Awareness: Environmental services staff trained on patient privacy in clinical areas, including handling of materials that may contain protected health information.
• Joint Commission & AAAHC Survey Support: Documentation, audit trails, and quality control reports formatted to support accreditation surveys.

ATP Bioluminescence Verification — Proof Your Facility Is Truly Clean

Visual inspection only confirms that surfaces look clean. ATP (Adenosine Triphosphate) bioluminescence testing measures the amount of organic residue on a surface in 10 seconds — providing objective, numerical proof of disinfection effectiveness. This is the same technology used by infection prevention programs in major U.S. hospitals.

We offer ATP verification testing as part of our standard quality control program. Pass/fail readings are logged for each tested surface, giving your facility documented evidence of cleaning effectiveness for accreditation surveys, internal quality reviews, and patient safety committees.

Most healthcare facilities in Massachusetts have never had their surfaces objectively verified — not because they don't care, but because nobody has offered them the technology. Until now.